IgA nephropathy trials in Saudi Arabia

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

  Where

  Riyadh

  Age

  2 years to 18 years

  People

  31 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06994845
• Phase 2Taking people
  Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

  Where

  Riyadh

  Age

  18 years to 99 years

  People

  20 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06797518